Sponsor:
UCLA
Code:
NCT07222618
Conditions
Multiple Sclerosis
Multiple Sclerosis (MS) - Relapsing-remitting
Multiple Sclerosis (MS) Primary Progressive
MS (Multiple Sclerosis)
MS
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Multiple Sclerosis
Multiple Sclerosis (MS) - Relapsing-remitting
Multiple Sclerosis (MS) Primary Progressive
MS (Multiple Sclerosis)
MS
Study ID
NCT07222618
Start date
Oct 1, 2025
Status verified date
Oct, 2025
Completion date
Oct 1, 2028
Anticipated
Primary completion date
Oct 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Primary outcome measure
Central contacts
Locations
University of California, San Francisco
Recruiting
San Francisco, California, United States, 94158
Contacts
Principal Investigator:
Riley Bove, MD
Sponsor
University of California, San Francisco
Last update posted
Oct 31, 2025
Last verified
Oct, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2025-10-31.